Friday, January 12, 2007

Recommendations For Early Breast Cancer Screening

Women need to empower themselves about the benefits and risks of mammography and examine the additional screening tools available today. One current philosophy suggests breast health screening should begin at age 25. Where does this recommendation come from and why is this valid?

For MOST women, the recommendation for annual breast cancer screening begins at the age of 40. Unfortunately, the American Cancer Society stated that the number one cause of death in women between the ages of 40-44 is breast cancer. So what does this mean for women? It means that we screen at age 40 and potentially find tumors that have been growing for an estimated 8-10 years. Mammography, like most conventional tests, evaluates structure.

There exists a technology that can detect an issue YEARS before a tumor can be seen on X-ray or palpated during an exam. This technology has been approved by the FDA as an adjunctive screening tool since 1982 and offers NO RADIATION, NO COMPRESSION AND NO PAIN. For women who are refusing to have a mammogram or those who want clinical correlation for an existing problem, digital infrared thermal imaging may be of interest.

There are very strict protocols both for testing and interpreting. Perhaps due to these guidelines, thermography (as with all digital technology) has exploded in its technique and capabilities. Thermal cameras detect heat emitted from the body and display it as a picture on a computer monitor. These images are unique to the person and remain stable over time. It is because of these characteristics that thermal imaging is a valuable and effective screening tool. Tumors or other breast diseases measures warmer than surrounding tissue and can thereby alert a physician to a problem before a tumor is actually palpable.

Medical doctors who interpret the breast scans are board certified and endure an additional two years of training to qualify as a thermologist. Thermography is not limited by breast density and is ideal for women who have had cosmetic or reconstructive surgery. It is recommended that since cancer typically has a 15 year life span from onset to death, women begin thermographic screenings at age 25. As previously mentioned, the number one killer of women ages 40-44 is breast cancer. Therefore, a woman diagnosed with breast cancer at age 40 possibly had the cancer as early as age 30. Since most women do not have a mammogram until age 40, there is a critical time period from age 25 to 39 that thermography could be especially beneficial. Thermography, because it analyzes function, may identify a problem years earlier. DITI may allow women time and opportunity to support their immune system, change their lifestyle and give their body the best chance to alter their fate.

By combining both technologies, the detection rate increases to 95-98%, surpassing either technology as a stand-alone therapy. Thermography, like mammography, is a personal choice for women. This decision ideally should be made in collaboration between you and your physician. However, thermography does not require a physician’s order.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

writer:Brenda Witt

posted by Mohd Firdaus at 6:13 AM | Permalink | 0 comments

 

 

Monday, January 01, 2007

Prempro Breast Cancer Risks
While Prempro may cure your hot flashes, it may also debilitate or kill you from ovarian cancer, breast cancer, endometrial cancer, and stroke.

Since 1995, millions of women have confidently taken Prempro, a leading hormone replacement therapy drug, prescribed to treat postmenopausal hot flashes and other menopausal symptoms.

However, a recent major study concludes that long-term use of Prempro has significantly increased the risk of stroke, blood clots, Prempro ovarian cancer, endometrial cancer, and breast cancer, while maximizing the risk for dementia and Alzheimer’s disease. Evidence has revealed that Prempro and other estrogen progestin combinations can actually harm perfectly healthy women.

These results were found in the nation's largest hormone replacement study and were so alarming that the National Institute of Health (NIH) prematurely canceled the study citing risk to the participants. As a result the study is suggesting that many of the women who use Prempro and other estrogen and progestin combinations should quit and talk to their doctors about Prempro alternatives.

Prempro is manufactured by Wyeth Pharmaceuticals. In 2001 Prempro accounted for approximately $890 million of the company's $13.9 billion in sales.

writer:Michael@Monheit.com - Michael Monheit, Esquir
posted by Mohd Firdaus at 11:30 PM | Permalink | 0 comments

 

  Bunnyrich Topsite List

    Web Adsense Topsite List

  Best Malaysian Sites